Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Partners L. P/il Bvf currently holds 6,068 shares of NPS PHARMACEUTICALS INC (NPSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners L. P/il Bvf has been a net buyer of NPSP stock. They have purchased $30.1M and sold $10.0M worth of shares.
Partners L. P/il Bvf's most recent insider trade was on Jun 24, 2026, when they sold 6,068 shares at $0.00 per share.
Partners L. P/il Bvf serves as Executive at NPS PHARMACEUTICALS INC (NPSP). They have executed 174 insider transactions totaling $40.2M over their tenure at the company.
Partners L. P/il Bvf holds the position of Executive at NPS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Partners L. P/il Bvf has shown a buying trading pattern, with $30.1M in total purchases and $10.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Partners L. P/il Bvf was on Apr 4, 2018, when they sold $3.7M worth of ARQL shares. This transaction involved 1,269,634 shares at $2.90 per share.
Partners L. P/il Bvf currently owns 6,068 shares of NPS PHARMACEUTICALS INC (NPSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Partners L. P/il Bvf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Partners L. P/il Bvf has 174 Form 4 filings on record as an insider at NPS PHARMACEUTICALS INC.
Set alerts for Partners L. P/il Bvf and 40,000+ other insiders.